KIOBRINA
Swedish Orphan Biovitrum AB (publ)
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79144177 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | M30 |
| Employee Name | SANTOMARTINO, MARTHA L |
Timeline
| 2013-11-13 | Application Filed |
| 2014-09-25 | Abandon |
| 2014-10-28 | Location: TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED |
| 2014-10-28 | Status: Dead/Abandoned |
| 2019-12-20 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Swedish Orphan Biovitrum AB (publ) |
| Entity Statement | Aktiebolag |
| Address | Berzelius väg 8 SE-112 76 Stockholm SE |
| Legal Entity Type | |
| Legal Entity State | SE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 29 |
| U.S. Codes: | 046 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical and dietetic preparations, being preparations for enzyme therapy to restore lipase activity for enhanced growth, neurodevelopment and to increase uptake of long chain polyunsaturated fatty acids, and for use as dietary supplements |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2014-03-20 | 1 REPR M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2014-03-21 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-03-22 | 3 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2014-03-22 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2014-03-22 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2014-03-23 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2014-03-24 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2014-03-24 | 8 RFCS P: |
| APPLICATION FILING RECEIPT MAILED | 2014-03-26 | 9 MAFR O:Outgoing Correspondence |
| REFUSAL PROCESSED BY IB | 2014-04-11 | 10 RFNT P: |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2014-10-28 | 11 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2014-10-28 | 12 MAB2 O:Outgoing Correspondence |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2015-08-26 | 13 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2015-08-26 | 14 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2015-09-11 | 15 OPNX P: |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2015-10-28 | 16 FICR P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2015-10-28 | 17 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2015-11-17 | 18 FINT P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2016-03-31 | 19 NREP P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2019-12-20 | 20 NREP P: |
| DEATH OF INTERNATIONAL REGISTRATION | 2024-06-10 | 21 DETH P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 KIOBRINA 79144177 not registered Dead/Abandoned |
Swedish Orphan Biovitrum AB (publ) 2013-11-13 |
 KIOBRINA 79016133 3215968 Dead/Cancelled |
Arexis AB 2005-09-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 